Early COVID-Related pandemic impacts and subsequent opioid outcomes among persons receiving medication for opioid use disorder: a secondary data analysis of a Type-3 hybrid trial
CONCLUSIONS: Mitigating the effect of the pandemic on patients' interpersonal relationships and employment, and promoting greater infection control in opioid treatment programs, could be protective against negative opioid-related outcomes. Trial registration The present study describes secondary data analysis on a previously registered clinical trial: clinicaltrials.gov/ct2/show/NCT03931174.PMID:37705105 | DOI:10.1186/s13722-023-00409-7
Source: Addiction Science and Clinical Practice - Category: Addiction Authors: Tim Janssen Bryan R Garner Julia Yermash Kimberly R Yap Sara J Becker Source Type: research
More News: Addiction | Clinical Trials | COVID-19 | Employment | Epidemics | Epidemiology | Overdose | Pandemics | Science | Study